Rocket One (RKTO) Non Operating Income (2019 - 2026)
Rocket One's (RKTO) quarterly Non Operating Income came in at $149.0 in Q2 2026, down 13.87% year-over-year from $173.0 in Q2 2025, and up 100.34% quarter-over-quarter from -$44016.0 in Q1 2026.
Powered by 
Analysis
Rocket One (RKTO) Non Operating Income (2019 - 2026) Analysis & Trends
Rocket One has disclosed Non Operating Income across 8 years of filings, most recently posting $149.0 for Q2 2026.
- In Q2 2026, Non Operating Income fell 13.87% year-over-year to $149.0; the TTM figure through Jun 2026 stood at -$152174.0 (down 20498.66% YoY), while the FY2025 annual figure was -$107953.0, down 497.88% from the prior year.
- Non Operating Income came in at $149.0 for Q2 2026 at Rocket One, up from -$44016.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $89187.0 in Q1 2022 to a low of -$378046.0 in Q2 2022.
- Average Non Operating Income over 5 years is -$32457.5, with a median of $177.0 recorded in 2025.
- Year-over-year, Non Operating Income soared 1101.01% in 2022 and tumbled 43417.71% in 2025.
- Over 5 years, Non Operating Income stood at -$57722.0 in 2022, then surged by 92.29% to -$4453.0 in 2023, then soared by 104.31% to $192.0 in 2024, then plunged by 43417.71% to -$83170.0 in 2025, then surged by 100.18% to $149.0 in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were $149.0 in Q2 2026, -$44016.0 in Q1 2026, and -$83170.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.77 Bn | 197.79 Bn | 7.24 Bn | -73.00 Mn |
| 2 | Gilead Sciences | 181.13 Bn | 177.95 Bn | 6.22 Bn | 387.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.24 Bn | 124.39 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.89 Bn | 3.93 Bn | 234.30 Mn |
| 5 | Argenx Se | 61.56 Bn | 56.38 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.38 Bn | 49.24 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.44 Bn | 31.13 Bn | 992.69 Mn | -53.64 Mn |
| 8 | Biogen | 31.17 Bn | 29.89 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.12 Bn | 30.12 Bn | 1.16 Mn | - |
| 10 | Rocket One | 13.80 Mn | 5.90 Mn | - | 149.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 149.00 |
| Mar 31, 2026 | -44,016.00 |
| Dec 31, 2025 | -83,170.00 |
| Sep 30, 2025 | -25,137.00 |
| Jun 30, 2025 | 173.00 |
| Mar 31, 2025 | 181.00 |
| Dec 31, 2024 | 192.00 |
| Sep 30, 2024 | 200.00 |
| Jun 30, 2024 | 13,365.00 |
| Mar 31, 2024 | 13,375.00 |
| Dec 31, 2023 | -4,453.00 |
| Sep 30, 2023 | 6,397.00 |
| Jun 30, 2023 | -164,402.00 |
| Mar 31, 2023 | 9,310.00 |
| Dec 31, 2022 | -57,722.00 |
| Sep 30, 2022 | 40,182.00 |
| Jun 30, 2022 | -378,046.00 |
| Mar 31, 2022 | 89,187.00 |
| Dec 31, 2021 | -99,979.00 |
| Sep 30, 2021 | -42,852.00 |